先導計劃為申請人注射的是含人類乳頭瘤病毒 (HPV) 6、11、16、18、31、33、45、52及58型L1蛋白的九合一疫苗，可預防由疫苗內含相關HPV病毒引致的生殖器疣、子宮頸 / 陰道 / 外陰 / 肛門的癌前病變及癌症。
The vaccine used in this Pilot Scheme contains Human Papillomavirus (HPV) 6, 11, 16, 18, 31, 33, 45, 52, 58 L1 protein. It prevents genital warts, premalignant genital lesions and cancers affecting the cervix, vulva, vagina and anus caused by HPV types included in the vaccine.
Based on the information from the vaccine’s manufacturer, 3 doses of the vaccine should be given within half a year. After the first injection, the second injection will be given 2 months later and the third injection will be given after another 4 months. Girls who are 14 years old or younger only need two doses, so the first injection will be followed 6 months later by the second injection. Currently there is no evidence that further booster is needed.
The safety of the HPV vaccine is widely accepted by many monitoring agencies in USA, Canada, Europe, and the World Health Organization. Transient reactions after injection include: pain and swelling at the injection site, skin redness or itching, fever, headache, etc.
If the problem persists, you should consult a doctor and tell the doctor about your recent vaccination. Please inform our doctor before injection if you have any of the following conditions: allergic reaction to yeast or vaccines; pregnancy; disease of the immune system; low platelet count; blood clotting problem causing continued bleeding after injection, injury or tooth extraction; and any fever or medication taken on that day.
Prevention of cervical cancer takes more than HPV vaccination. Avoid risky sexual behavior by maintaining a stable and monogamous relationship, using a condom every time, and do not smoke or drink alcohol, so that your own immune system can resist the virus.
Vaccination is not 100 percent effective in preventing cervical cancer. Women should start to have regular cervical smear examination when they reach the age of 25.